XGN(Exagen Inc.) · 财务报表

XGN(Exagen Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$48.30M$45.56M$52.55M$55.64M$66.58M
毛利润$27.71M$21.35M$29.46M$33.11M$38.80M
营业利润−$24.07M−$46.05M−$22.84M−$13.64M−$14.07M
净利润−$26.85M−$47.39M−$23.69M−$15.12M−$19.95M
经营现金流−$20.27M−$32.14M−$14.46M−$13.28M−$13.62M
自由现金流−$22.64M−$36.46M−$15.29M−$13.79M−$14.27M
摊薄每股收益$-1.68$-2.77$-1.34$-0.83$-0.93

Exagen Inc. XGN